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Assessing the daily stability of the cortisol
awakening response in a controlled
environment
Greg J. Elder1*, Jason G. Ellis2, Nicola L. Barclay2 and Mark A. Wetherell2
Abstract
Background: Levels of cortisol, the end product of the hypothalamic-pituitary-adrenal (HPA) axis, display a sharp
increase immediately upon awakening, known as the cortisol awakening response (CAR). The daily stability of the
CAR is potentially influenced by a range of methodological factors, including light exposure, participant adherence,
sleep duration and nocturnal awakenings, making inferences about variations in the CAR difficult. The aim of the
present study was to determine the daily stability of multiple measurement indices of the CAR in a highly-
controlled sleep laboratory environment. A secondary aim was to examine the association between objective sleep
continuity and sleep architecture, and the CAR.
Methods: The CAR was assessed in 15 healthy normal sleepers (seven male, eight female, Mage = 23.67 ± 3.49 years)
on three consecutive weekday mornings. Sleep was measured objectively using polysomnography. Saliva
samples were obtained at awakening, +15, +30, +45 and +60 min, from which multiple CAR measurement
indices were derived: cortisol levels at each time point, awakening cortisol levels, the mean increase in
cortisol levels (MnInc) and total cortisol secretion during the measurement period. Morning 2 and Morning 3
awakening cortisol levels, MnInc and total cortisol secretion were compared and the relationship between
Night 1 and Night 2 objective measures of sleep continuity and architecture, and the subsequent CAR, was
also assessed.
Results: There were no differences in cortisol levels at each time point, or total cortisol secretion during the
CAR period, between Morning 2 and Morning 3. Awakening cortisol levels were lower, and the MnInc was
higher, on Morning 3. Morning 2 and Morning 3 awakening levels (r = 0.77) and total cortisol secretion
(r = 0.82), but not the magnitude of increase, were positively associated.
Conclusions: The stability of the CAR profile and total cortisol secretion, but not awakening cortisol levels or
the magnitude of increase, was demonstrated across two consecutive mornings of measurement in a
highly-controlled environment. Awakening cortisol levels, and the magnitude of increase, may be sensitive
to differences in daily activities.
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Background
The stress hormone cortisol is the end product of the
hypothalamic-pituitary-adrenal (HPA) axis, a system
which aids the adjustment and adaptation to bodily and
environmental challenges [1, 2]. This system is under
the overall co-ordination of the suprachiasmatic nucleus
(SCN), which is the body’s central pacemaker [3]. Corti-
sol secretion follows a diurnal pattern with a sharp in-
crease in the first hour following awakening, which is
known as the cortisol awakening response (CAR). Dur-
ing the CAR period, cortisol levels increase by 38–75 %,
peaking approximately 30–45 min post-awakening [1, 4].
Multiple measurement indices can be used to assess the
CAR, including cortisol levels at specified time points
(e.g. immediately upon awakening), the magnitude of in-
crease in cortisol levels, and total cortisol secretion dur-
ing the CAR measurement period [4].
It is estimated that 73–77 % of healthy adults display a
typical CAR [5], although the exact function of the CAR
is still not known [6]. It has been speculated that the
CAR may help promote arousal upon awakening, or as-
sist in the recovery from previous experiences [7–9]. It
has also been suggested that the CAR is a marker of an-
ticipation; specifically reflecting the preparation for the
forthcoming demands of a particular day [1, 10]. Despite
the widespread use of the CAR as a comparative marker
of HPA axis function within a diverse range of popula-
tions [11–14], little is known about the daily stability of
the CAR. The CAR shows a great degree of variability
when measured between days, meaning that the CAR of
a single day appears to be largely affected by situational
factors, such as mood or light levels, rather than trait
factors. Due to this, multiple measurement days are
needed in order to reliably assess the CAR [15].
To date, only one study has measured the CAR in a
sleep laboratory environment in normal healthy sleepers,
where sleep was not disrupted or manipulated [16] and
there are no studies which have examined the CAR over
consecutive days in a sleep laboratory environment. Of
the other studies which have examined the CAR in a
sleep laboratory, the aim has been to examine the
subsequent CAR following an experimental manipula-
tion [e.g. 17]. Although Hellhammer and colleagues
recommend the collection of the CAR over multiple
days of measurement, this is based on ambulatory
CAR data [15]. The majority of studies which meas-
ure the CAR have done so in an ambulatory environ-
ment. However, these studies can be influenced by a
range of methodological factors, potentially resulting
in misleading or erroneous results.
Firstly, ambulatory studies typically require unsuper-
vised participants to self-collect samples, and poor levels
of adherence to sampling protocols can dramatically in-
crease measurement error [4]. This issue was highlighted
in one study which tracked sampling times using time-
stamped saliva collection bottles, which observed an ad-
herence rate of 74 % [18]. Importantly, participant non-
adherence had the greatest impact upon the resulting
CAR profile, and the majority (82 %) of non-adherent
participants failed to collect two or more samples at re-
quired time points [18]. Non-adherence to the awaken-
ing sample is particularly problematic, as a delayed
awakening sample can flatten the peak, relative to awak-
ening cortisol levels, and thus mimic a deficiency [19,
20]. The potential for poor adherence is therefore one of
the main limitations of ambulatory CAR measurement
and can be overcome by measuring the CAR in a super-
vised, laboratory environment.
Secondly, ambulatory CAR studies are also likely to be
influenced by intra-individual differences in environ-
mental light exposure, either prior to or during the CAR
measurement period. This is of importance to the CAR,
since the SCN, which is sensitive to light, co-ordinates
the HPA axis [3]; thus, light levels are likely to influence
the resulting CAR. The influence of light upon various
measurement indices of the CAR has been confirmed by
several experimental studies [7, 21, 22].
Thirdly, sleep may also affect the daily stability of the
CAR, as sleep duration, the occurrence and duration of
nocturnal awakenings, and the time of awakening are all
likely to influence the CAR [23]. In order to account for
these factors, a highly controlled and consistent meas-
urement environment is needed, across multiple days of
measurement. In ambulatory studies participants are
generally unsupervised overnight prior to the collection
of the CAR. Therefore, nocturnal awakenings may influ-
ence the CAR, although these data are generally not col-
lected, or are self-reported. Although actigraphy, which
provides objective information regarding sleep continu-
ity, has been employed in ambulatory studies, this has
mainly been used to assess whether self-reported awak-
ening times match objective awakening times [24, 25]. A
further limitation of actigraphy is that despite the ability
to provide more detailed sleep information, this cannot
prevent the resulting CAR being influenced by intra-
individual differences in sleep architecture [23].
The basic relationship between objective sleep con-
tinuity and architecture and the CAR in healthy normal
sleepers is currently unclear, as a previous study did not
directly examine this relationship in healthy individuals
in a sleep laboratory environment [16], and inconsistent
findings have previously been observed in the few stud-
ies which have examined clinical populations [23]. For
example, a study of army veterans with post-traumatic
stress disorder did not observe a relationship between
sleep architecture and total plasma cortisol secretion
during the CAR period [26]. Further, in a sample of
alcohol-dependent inpatients, a negative association
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between the duration of rapid eye movement (REM)
sleep and awakening cortisol levels was observed
[27]. In a study combining dementia caregivers and
non-caregivers, the percentages of sleep spent in
stage 1, stage 3 and REM were negatively related to
overall awakening cortisol levels, however, it is likely
that these results were confounded by between-
group differences [28]. As the relationship between
objective sleep measures and the CAR is unclear in
healthy, normal sleepers, this should first be investi-
gated in a highly-controlled manner before being ex-
tended to other populations.
A laboratory environment ensures that sleep duration
can be closely monitored, and accounted for if necessary.
In the case of sleep duration, the findings are mixed and
the relationship between the CAR and sleep duration
appears to be influenced by the study design and the
choice of CAR measurement indices [5, 29–32]. For ex-
ample, whilst Kumari and colleagues observed that indi-
viduals with a short sleep duration (less than 5 h)
displayed a steeper rise in cortisol levels between awak-
ening and +30 min in a large sample of middle-aged
adults [29], a meta-analysis indicated that the most con-
sistent association was a positive relationship between
sleep duration and awakening cortisol levels [33]. Add-
itionally, little is known about whether differences in the
mode of awakening can affect the CAR; on the basis of
one single-case study, the CAR did not differ when ob-
served in response to natural awakening, or an awaken-
ing caused by an alarm clock [30]. However, a laboratory
environment can ensure that the mode of awakening is
consistent for all participants (i.e. where all participants
have either natural or forced awakenings).
In order to accurately determine whether the CAR
is stable, a highly-controlled measurement environ-
ment, with the simultaneous monitoring of sleep, is
needed to ensure high levels of control over relevant
methodological factors. Specifically, a sleep laboratory
environment ensures that environmental light levels
are standardised prior to and during the CAR meas-
urement period, that other circadian factors including
food intake can be taken into account, that nocturnal
awakenings are monitored, and that the mode of
awakening is consistent between participants, whilst
allowing the careful and accurate monitoring of sleep
prior to the measurement of the CAR. This environ-
ment can also maximise participant adherence by
ensuring that the awakening sample is obtained at the
appropriate time point, therefore reducing measure-
ment error.
The aim of the present study was to determine the
daily stability of multiple measures of the CAR in
healthy normal sleepers, with the simultaneous objective
monitoring of sleep, within a highly-controlled sleep
laboratory environment. A secondary aim of the study
was to assess the basic relationship between measures of
objective sleep continuity and architecture and the CAR
in healthy normal sleepers, given the paucity of research
in healthy populations. In order to comprehensively as-
sess the CAR, the CAR was expressed as cortisol levels
at each measurement time point, awakening cortisol
levels, the mean increase in cortisol levels and total cor-
tisol secretion during the measurement period.
Methods
Participants
Eighteen non-smoking healthy normal sleepers (nine
male, nine female; Mage = 23.46 years, SDage = 3.21 years)
were recruited from the staff and student population of
Northumbria University using email advertisements.
Participants provided written informed consent and
were paid £150 upon completion of the study. The study
was approved by Northumbria University Faculty of
Health Sciences Ethics Committee.
Procedure
The study procedure is summarised in Figure 1. In
order to ensure that participants were healthy good
sleepers, all participants were screened for current or
previous sleep problems; physical illnesses; shift work;
or trans-meridian travel in the three months prior to
study enrolment, on the basis of a clinical interview
with a member of the research team. In order to de-
termine habitual sleep/wake schedules and verify their
stability, participants completed self-reported sleep
diaries [34] and wore an actigraph in the two weeks
prior to the laboratory stay. Actigraphy data were
visually inspected for any evidence of circadian abnor-
malities before commencing the laboratory study.
Participants slept for three consecutive weekday
nights in a sleep laboratory (Adaptation Night, Night
1 and Night 2), where sleep was measured objectively
using polysomnography (PSG).
The CAR was measured on each of the weekday
mornings (Morning 1, Morning 2 and Morning 3),
where participants were awoken by a researcher at their
scheduled awakening time. Participants were prohibited
from eating, drinking (with the exception of a small
amount of water), or brushing their teeth, either before
or during the measurement period, in order to avoid the
potential contamination of saliva samples through abra-
sion or vascular leakage [4, 35].
Participants left the sleep laboratory approximately one
hour after the final saliva sample was obtained on Morning
1 and were instructed to follow their habitual daily routine.
Between Night 1 and Morning 3 (a period of approximately
30 h) participants remained in the sleep laboratory, under
observation, in order to ensure a stable and consistent
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environment. Participants were permitted to perform seden-
tary activities during this period, including reading, watching
television or films. During this period, participants were not
permitted to leave the laboratory at any point. Standardised
meals were provided at identical time points (+2, +6 and
+10 h post-awakening) in order to avoid any potential circa-
dian effects of food intake. Participants were debriefed and
were allowed to leave the laboratory one hour after the
final saliva sample was obtained on Morning 3.
Cortisol awakening response
The CAR was measured on three consecutive week-
day mornings (Morning 1, Morning 2 and Morning
3), where saliva samples were obtained immediately
upon awakening, and at +15, +30, +45 and +60 min
post-awakening. All saliva samples were collected in
the presence of a researcher, who did not engage the
participant in conversation during the measurement
period. Saliva samples were obtained using Salivettes
(Sarstedt, Leicester, UK). To ensure consistency and
the collection of sufficient saliva for assaying, all
participants were instructed to chew on Salivettes for
60 s.
Saliva samples were stored in a domestic refriger-
ator immediately following collection, before being
frozen at −20 °C at the earliest opportunity, until
assaying. Samples were centrifuged at 3000 rpm for
15 min and all assays were performed in-house in
order to avoid the potential influence of inter-
laboratory analytical variations [36, 37]. All assays
were performed using the luminescence immunoassay
method, in accordance with manufacturer instructions
(Salimetrics, Newmarket, UK; inter-assay coefficients
<10 %). Assays were performed in the same laboratory,
using identical techniques, in order to avoid bias [36].
Sleep environment
Participants slept in a windowless room within a sleep
laboratory and were awoken by a researcher at their pre-
determined awakening time, which was scheduled in
accordance with their average weekday bedtime and
average awakening time from their baseline sleep diaries.
All saliva samples were collected in constant low-
intensity ultraviolet light, of approximately one lux, to
minimise the influence of light input upon the CAR.
Participants were instructed to remain supine in bed
during the measurement period.
Measures
Polysomnography
Sleep was monitored objectively using PSG. Recording
times were scheduled in accordance with average week-
day habitual bedtimes and awakening times (on the basis
of baseline two week sleep diary sleep/wake schedules),
and did not vary across the laboratory period. Electro-
encephalogram (EEG) electrodes were placed at FP1,
FP2, F3, F4, C3, C4, P3, P4, O1, O2 and Cz, referenced to
linked mastoids (M1, M2) and a ground electrode (FPz).
PSG also included chin and anterior tibialis electromyo-
gram (EMG), electrooculogram (EOG) and electrocar-
diogram (ECG) channels, during all recording nights.
PSG was recorded using a SOMNOscreen system
(SOMNOmedics GmbH, Randersacker, Germany) and
impedance levels were maintained below 5kΩ. Recordings
Fig. 1 Study procedure
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were blind-scored in 30-s epochs by an external
scorer, where sleep stages were scored in accordance with
American Academy of Sleep Medicine guidelines [38].
Data analysis
Objective measures of sleep continuity (total sleep time
(TST); sleep efficiency (SE%); sleep onset latency (SOL);
the number of awakenings (NWAK), wake after sleep
onset (WASO)), sleep architecture (percentages of sleep
spent in wake, rapid eye movement sleep (REM), stage 1
(N1), stage 2 (N2) and stage 3 (N3); and the latency to
each stage of sleep) were derived from PSG data. These
measures are described in Table 1.
The CAR was assessed through the measurement of
cortisol levels at each sampling time point (measured in
nanomoles per litre (nmol/l), awakening cortisol levels,
the mean increase in cortisol levels during the measure-
ment period (MnInc) and total cortisol secretion during
the measurement period. The MnInc was derived from
the average cortisol levels of all post-awakening samples
(measured between +15 and +60 min) [5]. Total cortisol
secretion was calculated using the area under the curve
with respect to ground (AUCG) formula [39] and was
expressed in arbitrary units. Shapiro-Wilk tests, con-
ducted on cortisol levels in order to assess normality,
were not significant (all p-values >0.05) and non-
transformed cortisol data were used in all subsequent
analyses.
PSG data from the Adaptation Night were excluded
from further analyses, as PSG alterations are typically
observed during the first night of sleep in a laboratory
environment [40, 41]. Morning 1 CAR data were also re-
moved for this reason. CAR data from three participants
were excluded due to saliva samples containing an
insufficient volume of saliva for analysis (n = 2) and due
to consistently and excessively high cortisol levels
[>75 nmol/l; 42] (n = 1). This resulted in a final sample
of 15 participants (Fig. 2).
A 2 (morning) × 5 (time point) analysis of variance
(ANOVA) was conducted in order to compare cortisol
levels during the measurement period between Morning
2 and Morning 3, and between each sampling time
point. Greenhouse-Geisser adjusted degrees of freedom
are reported where appropriate. Effect sizes are reported
using partial eta squared (η2p) values. Paired t-tests were
used to compare Morning 2 and Morning 3 CAR indices
(awakening levels, MnInc and AUCG). Post-hoc power
analyses for these comparisons were calculated using
G*Power 3.1 [43].
In order to examine the specific relationship between
measures of objective sleep continuity and architecture
and CAR indices, Spearman rank correlations were used
to examine the association between objective measures
of sleep continuity and architecture (TST, SE%, SOL,
NWAK, WASO, percentages of sleep spent in N1, N2,
N3 and REM, and the latencies to N1, N2, N3 and
REM) and CAR measurement indices (awakening levels,
MnInc and AUCG). This association was examined sep-
arately between Night 1 and Morning 2, and between
Night 2 and Morning 3. All significance values were ad-
justed using Bonferroni corrections (p = 0.05/39), result-
ing in an adjusted significance threshold of p = 0.0013.
Pearson correlations were used to examine the test-
retest reliability of the CAR measurement indices be-
tween Morning 2 and Morning 3.
Results
The final sample consisted of 15 healthy sleepers (seven
male, eight female, Mage = 23.67 years, SDage = 3.49 years)
showing normal sleep patterns, as verified by summary
PSG data (Table 2).
Test-retest correlation results showed significant posi-
tive associations between Morning 2 and Morning 3
awakening levels (r = 0.77, p = 0.001) and total cortisol
secretion (AUCG: r = 0.82, p < 0.001). The association be-
tween the Morning 2 and Morning 3 CAR MnInc was
not significant (r = 0.08, p > 0.05).
As expected, comparisons of cortisol levels at each meas-
urement time point between Morning 2 and Morning 3
showed a significant main effect of time point
(F(4,56) = 7.44, p < 0.001, η2p = 0.35), reflecting the typical
change in cortisol levels over the CAR measurement
Table 1 Measures of objective sleep continuity and sleep architecture derived from polysomnography data
Measure Description
Total sleep time (TST) The number of minutes scored as N1, N2, N3 or REM sleep.
Sleep onset latency (SOL) The elapsed time from lights out to the first epoch classified as sleep.
Number of awakenings (NWAK) The number of stage wake occurrences.
Wake after sleep onset (WASO) Minutes scored as wake from the first epoch of sleep to lights on.
Sleep efficiency (SE%) Total sleep time (TST) as a percentage of total recording time (TRT) ((TST / TRT x 100) = SE%).
Time in Wake, N1, N2, N3 and REM (%) Time scored individually as N1, N2, N3 and REM sleep, as a percentage of total sleep time (TST).
REM, N1, N2 and N3 latency (mins) The elapsed time from lights out to the first epoch of stage REM, N1, N2 and N3 sleep in minutes.
Abbreviations: TST: total sleep time, SOL: sleep onset latency, NWAK: number of awakenings, WASO: wake after sleep onset, SE: sleep efficiency, REM: rapid eye
movement sleep, N1: stage 1 sleep, N2: stage 2 sleep, N3: stage 3 sleep
Elder et al. BMC Psychology  (2016) 4:3 Page 5 of 10
period (Fig. 3 & Additional file 1: Table S1). Cortisol levels
at each time point did not significantly differ based on the
morning of measurement (F(1,14) = 0.01, p > 0.05,
η2p = 0.00) and the morning × time point interaction was
not significant (F(2.84, 39.72) = 2.19, p > 0.05, η2p = 0.14).
Morning 2 and Morning 3 awakening cortisol levels,
MnInc and AUCG values are summarised in Table 3.
Compared to Morning 2, awakening cortisol levels were
significantly lower (t(14) = 2.75, p < 0.05) and the
MnInc was significantly larger (t(14) = −2.35, p < 0.05)
on Morning 3. Total cortisol secretion (AUCG) did
not significantly differ between Morning 2 and Morn-
ing 3 (t(14) = 0.16, p > 0.05). Post-hoc power analyses indi-
cated that the power for these comparisons were 0.83,
0.72 and 0.06 respectively, and that the study had 58 %
power to detect medium-sized effects (d = 0.50) in these
measures.
The Morning 2 MnInc showed a significant positive
association with the percentage of sleep spent in N2
during Night 1 (rs = 0.76, p < 0.0013). There were no
other significant associations between measures of
sleep continuity or architecture and CAR measure-
ment indices, either between Night 1 and Morning 2,
or Night 2 and Morning 3 (all p-values > 0.0013).
These are summarised in Additional file 2: Table S2
and Additional file 3: Table S3.
Discussion
The aim of the current study was to assess the daily sta-
bility of multiple measures of the CAR, in a sleep labora-
tory environment with extremely high levels of control
over environmental factors, whilst also accounting for
objective measures of sleep. These results indicate that
cortisol levels at each sampling time point, and total cor-
tisol secretion, are stable across two consecutive morn-
ings of measurement. However, awakening cortisol levels
were lower, and the magnitude of increase was higher,
on the second morning of measurement.
The present study also examined the specific relation-
ship between the CAR and objective sleep continuity
Fig. 2 Participant flowchart
Table 2 Average Night 1 and Night 2 objective sleep measures
(n = 15)
Mean SD
TST (mins) 430.12 26.46
SOL (mins) 14.28 11.07
NWAK 13.87 4.89
WASO (mins) 13.12 6.59
SE (%) 94.02 2.77
Time in REM (%) 22.36 3.20
Time in N1 (%) 3.60 1.20
Time in N2 (%) 53.94 5.15
Time in N3 (%) 20.10 5.02
Latency to REM (mins) 105.87 33.79
Latency to N1 (mins) 14.28 11.07
Latency to N2 (mins) 20.73 12.59
Latency to N3 (mins) 33.73 13.77
Abbreviations: N1: stage 1 sleep, N2: stage 2 sleep, N3: stage 3 sleep, NWAK:
number of awakenings, REM: rapid eye movement sleep, SE: sleep efficiency,
SOL: sleep onset latency, TST: total sleep time, WASO: wake after sleep onset
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and architecture in healthy normal sleepers. The results
indicated that whilst no objective measures of sleep con-
tinuity were associated with the CAR, specific architec-
tural properties of objective sleep during Night 1 were
related to the magnitude of the subsequent Morning 2
CAR. This association was not observed between Night
2 sleep and the Morning 3 CAR. Specifically, the per-
centage of time spent in N2 sleep during Night 1 was
positively associated with the magnitude of the subse-
quent Morning 2 CAR. However, in order to confirm
the causal relationship between the percentage of time
spent in N2 sleep and the subsequent CAR magnitude,
future studies should manipulate sleep architecture by
specifically disrupting N2 sleep. This approach will con-
firm whether changes to sleep architecture can directly
affect the subsequent CAR. Due to the modest statistical
power of the current study, other potential associations
between measures of the CAR and objective sleep con-
tinuity and sleep architecture should be examined in a
larger sample.
It is possible that the association between objective
sleep continuity and architecture is affected by age, as a
recent study in school-aged children observed a negative
relationship between total cortisol secretion (measured
using the AUCG) and both sleep duration and the per-
centage of slow wave sleep, and a positive relationship
between the AUCG and N2 sleep [44]. The authors
speculate that these results indicate that lower HPA axis
activity is associated with more restorative sleep in
children. However, this study examined the CAR in an
ambulatory environment and the both sleep and the
CAR may have been influenced by differences in meas-
urement environment and daily activities. The potential
influence of age could be examined further in a labora-
tory environment.
This study also indicates that both awakening corti-
sol levels and total cortisol secretion (AUCG), but not
the MnInc, display high levels of test-retest reliability
(r values of 0.77, 0.82 and 0.08 respectively). The
test-retest reliability of these CAR measures has pre-
viously been reported in a large sample of healthy
adults (n = 509), which observed significant test-retest
values between two consecutive days of ambulatory
sampling of r = 0.37 for awakening cortisol levels, r = 0.63
for AUCG values and r = 0.47 for MnInc values [5]. The
levels of test-retest reliability for awakening cortisol levels
and total cortisol secretion are higher in the present study
compared to those reported by Wüst and colleagues; po-
tentially due to the reduced influence of sleep, awakening
time and light levels prior to and during the CAR meas-
urement period. The present study also indicates that the
Fig. 3 Mean (±SEM) Morning 2 and Morning 3 cortisol levels at each measurement time point (n = 15)
Table 3 Cortisol awakening response measurement indices by
morning (n = 15)
Morning 2 Morning 3 M2 vs M3
Mean SD Mean SD p-value
Awakening levels (nmol/l) 8.85 4.47 6.80 3.61 0.016
AUCG(arbitrary units) 567.50 219.04 562.35 199.78 0.878
MnInc (nmol/l) 0.58 2.58 2.97 3.20 0.034
Abbreviations: AUCG : area under the curve with respect to ground, nmol/l:
nanomoles per litre, MnInc: mean increase
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MnInc does not have a good level of test-retest reliability.
Given the highly-controlled measurement environment in
the present study, the MnInc may be particularly sensitive
to daily activities, since a significantly higher MnInc was
observed on Morning 3. Given the potential anticipatory
role of the CAR [1, 10, 45], the sensitivity of the CAR to
daily activities should be examined further in a laboratory
environment.
It is a particular strength of the current study that en-
vironmental light levels were standardised, with no
intra-individual variability, and were consistent prior to
and during the measurement period, as participants
were exposed to a consistently low level of light of one
lux. This is an advantage over ambulatory studies, and is
of particular importance as environmental light can
affect various CAR indices [7, 21, 22]. The current study
ensured that there was no variation in environmental
light levels between participants and that light levels did
not vary across each morning of measurement, which
cannot be controlled for in ambulatory studies.
Additionally, in the current study, participants remained
under observation in the sleep laboratory between Night 1
and Morning 3. Due to the high levels of control, this
minimised the influence of other relevant circadian influ-
ences upon the CAR. Specifically, between Night 1 and
Morning 3, participants were not permitted to exercise,
were provided with standardised meals at identical time
points relative to their awakening time, and were not
permitted to leave the laboratory. This ensured that
participants remained in the same environment dur-
ing the observation period, with no intra-individual
variations in food intake, exercise or light exposure,
thus minimising the potential circadian influences of
these variables [46].
A further strength of the study is that as all saliva sam-
ples were obtained in the presence of a researcher, this
ensured full participant adherence with the required
sampling protocol. In particular, this ensured that the
awakening sample, which is especially sensitive to delays
in collection, was obtained immediately, therefore mini-
mising the corresponding measurement error [19, 20].
The close monitoring of participants before and during
the CAR period also avoided the risk of sample contam-
ination, as participants were not allowed to eat or drink
during this period. As the current study employed PSG
as a gold-standard method of objective sleep monitoring,
this ensured that the effects of objective sleep continuity
and architecture upon awakening cortisol levels, the
magnitude of increase and total cortisol secretion during
the CAR period were accounted for. The use of PSG to
monitor participants also ensured that all participants
were asleep prior to the awakening sample, and allowed
for the potential influence of nocturnal awakenings to be
removed.
The main limitation of the present study was in the
small sample size. That said, the sample size of the
present study is similar to the sample size of other stud-
ies where the CAR has been measured in healthy nor-
mative individuals in a sleep laboratory environment [16,
17]. Despite this, the study participants were well-
characterised and completed a two week period of sleep
diaries and actigraphy prior to the laboratory study. In
addition, the study results were not influenced by the
typical alterations to objective sleep observed during an
adaptation night. Whilst future studies may wish to rep-
licate the current findings in a larger sample of partici-
pants, the current study accounted for a range of
relevant environmental factors which were likely to in-
fluence the CAR.
A further limitation of this protocol include the
associated costs, and the time-intensive and labour-
intensive nature of the study, since a researcher is
required to monitor sleep prior to the CAR measure-
ment period and to supervise all saliva sampling.
However, these potential limitations are more than
outweighed by the extremely high levels of control
afforded by this measurement protocol; particularly as
the current study had the ability to account for the
effects of objective sleep continuity and architecture
upon multiple measurement indices of the CAR.
Specifically, in the current study all participants fully
adhered to the required sampling instructions due to
the researcher supervision. As the light levels were
controlled and standardised for every participant, the
CAR was unaffected by variations in environmental
light levels, ensuring that all CAR measurement indi-
ces were almost entirely unaffected by light input to
the SCN. From a feasibility perspective, the data of
three participants could not be used. As such, this
protocol may be most useful as an experimental, ra-
ther than a clinical, protocol.
The results of the current study indicate that the CAR,
in terms of cortisol levels at each measurement time
point, and total cortisol secretion during the measure-
ment period, is stable in a highly-controlled sleep labora-
tory environment. However, awakening cortisol levels
and the magnitude of increase in cortisol levels show
daily variations and may be sensitive to variations in
daily activities. As the current measurement protocol
and environment ensure that the CAR can be studied
in a highly controlled manner, where circadian and
methodological variables have a minimal influence
upon measurement indices, this protocol can be ex-
tended to assess the function of the CAR in more de-
tail, and also HPA axis functioning in sleep disorders.
Despite potential roles in arousal, recovery or antici-
pation [1, 8–10, 45], the precise function of the CAR
is yet to be confirmed.
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Conclusions
The CAR, in terms of cortisol levels at each time point
and the total amount of cortisol secreted during the
measurement period, is stable across two consecutive
mornings of measurement in a highly-controlled sleep
laboratory environment, when controlling for important
methodological factors. However, awakening cortisol
levels and the magnitude of increase show daily varia-
tions and are potentially sensitive to differences in daily
activities. Additionally, the Morning 2 CAR magnitude
was positively associated with the Night 1 percentage of
time spent in N2 sleep. This measurement protocol can
also potentially be used to examine the function of the
CAR and assess HPA axis function in various sleep
disorders.
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